Skip to main content
Midas Edge

CITIUS ONCOLOGY INC

For the period ended Dec 31, 2024. Filed Feb 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2024 · Filed Feb 14, 2025

CTOR$0.55+7.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 6. Exhibits

31.1Certification of the Principal Executive Officer pursuant to Exchange Act Rule 13a-14(a).*
31.2Certification of the Principal Financial Officer pursuant to Exchange Act Rule 13a-14(a).*
32.1Certification of the Principal Executive and Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.*
EX-101.INSInline XBRL Instance Document*
EX-101.SCHInline XBRL Taxonomy Extension Schema Document*
EX-101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document*
EX-101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document*
EX-101.LABInline XBRL Taxonomy Extension Label Linkbase Document*
EX-101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document*
EX-104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*
*Filed herewith.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.